OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
In an increasingly xenophobic country, Salt Lake City’s benevolent attitude toward immigrants is a strange anomaly. Can its ...
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
Affinity Bancshares, Inc. Adopts Stock Repurchase ProgramThe Associated PressCOVINGTON, Ga. COVINGTON, Ga.–(BUSINESS WIRE)–Jan 7, 2026– Affinity Bancshares, Inc. (the “Company”) (Nasdaq: AFBI), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results